Sleep Disorders clinical trials

Explore recruiting sleep disorders clinical trials.

Recruiting sleep disorders studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Sleep Disorders trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A double blind, placebo controlled, parallel, study to evaluate the effects of NAL in Obstructive Sleep Apnea Patients.

France, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Sleep and Temperature Disturbance as risk factors for Alzheimer's Disease in Down Syndrome: a Longitudinal Study.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized, Single-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of Melatonin Administration in Patients With Multiple Progressive Primary Sclerosis (MELATOMS)

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A randomized, double-blind, placebo-controlled, multicenter study evaluating the effect of a 12-week DHEA combination of 20 mg and 2 mg prolonged-release melatonin on sleep quality and mood in postmenopausal women.

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase 2/3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Participants with Alzheimer’s Disease Dementia

Italy, Slovakia, Spain, Poland, Czechia, Germany

Phase II and Phase III (Integrated) EU CTIS Study details

Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LEBV® and 2LXFS® on asthenia in patients with an EBV infection

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Sleep Disorders trials by city

Sleep Disorders in Toronto Sleep Disorders in Vancouver Sleep Disorders in Montreal Sleep Disorders in Calgary Sleep Disorders in Edmonton Sleep Disorders in Ottawa Sleep Disorders in Winnipeg Sleep Disorders in Quebec City Sleep Disorders in Hamilton Sleep Disorders in Kitchener Sleep Disorders in London Sleep Disorders in Halifax Sleep Disorders in New York Sleep Disorders in Los Angeles Sleep Disorders in Chicago Sleep Disorders in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease